From Bench to Bedside: Clinical Trials and Next Steps
The journey from laboratory breakthrough to patient treatment is underway. Recent pilot studies in animal models have demonstrated both safety and efficacy, paving the way for human clinical trials. Researchers are now optimizing nanobot designs and delivery systems to meet regulatory standards. While widespread clinical use may still be several years away, early trials could begin soon, offering hope that DNA nanobot-based therapies will soon reach patients in need.